A Multi-Center, Double-Blind, Placebo-Controlled Investigation of Silodosin in the Treatment of Subjects With Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.

Trial Profile

A Multi-Center, Double-Blind, Placebo-Controlled Investigation of Silodosin in the Treatment of Subjects With Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Feb 2012

At a glance

  • Drugs Silodosin (Primary)
  • Indications Prostatitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 May 2011 Results have been presented at AUA-2011 according to Watson Pharmaceuticals media release. Results were also reported in the media release.
    • 13 May 2011 Results published in the Journal of Urology.
    • 04 Nov 2009 Actual patient number (153) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top